Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder

Schizophrenia Research

Volumn 133, Issue 1-3, 2011, Pages 36-41

  Bodén, Robert ^a,b   Brandt, Lena ^a   Kieler, Helle ^a   Andersen, Morten ^a   Reutfors, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adherence; Antipsychotics; Epidemiology; Hospitalization; Outcome studies; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BIRTHPLACE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE REGISTRY; EDUCATIONAL STATUS; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SWEDEN; URBAN AREA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MEDICATION ADHERENCE; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SWEDEN; YOUNG ADULT;

EID: 81955160680     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.08.024     Document Type: Article

References (25)

1. Ascher-Svanum H., Faries D.E., Zhu B., Ernst F.R., Swartz M.S., Swanson J.W. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J. Clin. Psychiatry. 2006, 67(3):453-460.
2. Buchanan R.W., Kreyenbuhl J., Kelly D.L., Noel J.M., Boggs D.L., Fischer B.A., Himelhoch S., Fang B., Peterson E., Aquino P.R., Keller W. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr. Bull. 2009, 36(1):71-93.
3. Chen E.Y., Hui C.L., Dunn E.L., Miao M.Y., Yeung W.S., Wong C.K., Chan W.F., Tang W.N. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophr. Res. 2005, 77(1):99-104.
4. Cougnard A., Parrot M., Grolleau S., Kalmi E., Desage A., Misdrahi D., Brun-Rousseau H., Verdoux H. Pattern of health service utilization and predictors of readmission after a first admission for psychosis: a 2-year follow-up study. Acta Psychiatr. Scand. 2006, 113(4):340-349.
5. Crow T., MacMillan J., Johnson A., Johnstone E. A randomised controlled trial of prophylactic neuroleptic treatment. Br. J. Psychiatry 1986, 148(2):120-127.
6. Dalman C., Broms J., Cullberg J., Allebeck P. Young cases of schizophrenia identified in a national inpatient register-are the diagnoses valid?. Soc. Psychiatry Psychiatr. Epidemiol. 2002, 37(11):527-531.
7. Durbin J., Lin E., Layne C., Teed M. Is readmission a valid indicator of the quality of inpatient psychiatric care?. J. Behav. Health Serv. Res. 2007, 34(2):137-150.
8. Eaton W.W., Mortensen P.B., Herrman H., Freeman H., Bilker W., Burgess P., Wooff K. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization. Schizophr. Bull. 1992, 18(2):217-228.
9. Gitlin M., Nuechterlein K., Subotnik K.L., Ventura J., Mintz J., Fogelson D.L., Bartzokis G., Aravagiri M. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am. J. Psychiatry 2001, 158(11):1835-1842.
10. Lang K., Meyers J.L., Korn J.R., Lee S., Sikirica M., Crivera C., Dirani R., Menzin J. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr. Serv. 2010, 61(12):1239-1247.
11. Law M.R., Soumerai S.B., Ross-Degnan D., Adams A.S. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J. Clin. Psychiatry 2008, 69(1):47-53.
12. Marcus S.C., Olfson M. Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr. Bull. 2008, 34(1):173-180.
13. Menezes N.M., Arenovich T., Zipursky R.B. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol. Med. 2006, 36(10):1349-1362.
14. NICE_CG82 Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care 2009, National Institute for Health and Clinical Excellence, London, www.nice.org.uk/cg82.
15. Novick D., Haro J.M., Suarez D., Perez V., Dittmann R.W., Haddad P.M. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010, 176(2-3):109-113.
16. Olfson M., Mechanic D., Hansell S., Boyer C.A., Walkup J., Weiden P.J. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr. Serv. 2000, 51(2):216-222.
17. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999, 56(3):241-247.
18. Robinson D.G., Woerner M.G., Delman H.M., Kane J.M. Pharmacological treatments for first-episode schizophrenia. Schizophr. Bull. 2005, 31(3):705-722.
19. Subotnik K.L., Nuechterlein K.H., Ventura J., Gitlin M.J., Marder S., Mintz J., Hellemann G.S., Thornton L.A., Singh I.R. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am. J. Psychiatry 2011, 168(3):286-292.
20. Swett C. Symptom severity and number of previous psychiatric admissions as predictors of readmission. Psychiatr. Serv. 1995, 46(5):482-485.
21. Tiihonen J., Haukka J., Taylor M., Haddad P.M., Patel M.X., Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am. J. Psychiatry 2011, 168(6):603-609.
22. Vares M., Ekholm A., Sedvall G.C., Hall H., Jönsson E.G. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology 2006, 39(6):286-295.
23. Weiden P.J., Kozma C., Grogg A., Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv. 2004, 55(8):886-891.
24. Wettermark B., Hammar N., Fored C., Leimanis A., Otterblad Olausson P., Bergman U., Persson I., Sundström A., Westerholm B., Rosén M. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Drug Saf. 2007, 16(7):726-735.
25. Wung Y.-T., Chen C.-C., Chen F.-C., Lin C.-H. Schizophrenia patients discharged against medical advice at a mental hospital in Taiwan. Psychiatry Clin. Neurosci. 2010, 64(4):415-420.